Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 89
Filter
1.
Biomater Sci ; 3(6): 861-9, 2015 Jun.
Article in English | MEDLINE | ID: mdl-26221846

ABSTRACT

In order for patients to avail of the therapeutic benefits of antioxidant drugs efficiently and conveniently, a robust oral delivery system needs to be developed. However, a common problem in oral drug delivery is ensuring that the drug remains functionally intact even after it has passed through the acidic environment of the gastrointestinal (GI) tract. To protect drugs within the GI environment, we formulated a design based on encapsulating liposomal drugs by using an alginate matrix as a carrier. The liposomal drug was composed of manganese porphyrin (Mn-por), which has been developed as a mimic of superoxide dismutase (SOD), as the therapeutic agent based on the antioxidative effect, namely superoxide (O2˙(-)) inhibitory activity. A cytochrome c assay revealed that the O2˙(-) inhibitory activity of Mn-por could be maintained even after treatment with simulated gastric and intestinal fluids. We demonstrated that oral administration of the formulated drug significantly inhibited the growth of transplanted tumors in mice. The drug formulation presented in this study would be a good candidate for orally available systems, which can effectively deliver SOD mimics.


Subject(s)
Alginates/chemistry , Antioxidants/administration & dosage , Antioxidants/chemistry , Hydrogel, Polyethylene Glycol Dimethacrylate/chemistry , Manganese/chemistry , Metalloporphyrins/administration & dosage , Metalloporphyrins/chemistry , Superoxide Dismutase/administration & dosage , Superoxide Dismutase/chemistry , Administration, Oral , Animals , Chemistry, Pharmaceutical , Drug Delivery Systems , Glucuronic Acid/chemistry , Hexuronic Acids/chemistry , Humans , Liposomes , Mice , Superoxide Dismutase/metabolism
2.
Ann Oncol ; 26(5): 998-1005, 2015 May.
Article in English | MEDLINE | ID: mdl-25609248

ABSTRACT

BACKGROUND: The aim of this study was to determine the maximum-tolerated dose (MTD), safety, pharmacokinetics, and pharmacodynamics of OPB-51602, an oral, direct signal transduction activator of transcription 3 (STAT3) inhibitor, in patients with refractory solid tumors. PATIENTS AND METHODS: Three cohorts were studied: cohort A, a sequential dose escalation of OPB-51602 administered intermittently (days 1-14 every 21 days); cohort B, an expansion cohort evaluating the dose lower than the MTD; cohort C, evaluating continuous daily dosing. RESULTS: Fifty-one patients were studied at 2, 4, and 5 mg per day dosing. The MTD was 5 mg; first-cycle dose-limiting toxicities (DLTs) were grade 3 hyponatremia in one patient, and grade 3 dehydration in another. Intermittent dosing of both 2 and 4 mg doses were tolerable, and the recommended phase II dose was 4 mg. Cohort B investigated 4 mg intermittently, whereas cohort C investigated 4 mg continuously. Common toxicities included fatigue, nausea/vomiting, diarrhea, anorexia, and early-onset peripheral neuropathy. Drug-induced pneumonitis occurred in two patients in cohort C. Continuous dosing was associated with a higher incidence of peripheral neuropathy and a lower mean relative dose intensity, compared with intermittent dosing. Steady-state pharmacokinetics was characterized by high oral clearance, mean elimination half-life ranging from 44 to 61 h, and a large terminal-phase volume of distribution. An active metabolite, OPB-51822, accumulated to a greater extent than OPB-51602. Flow cytometry of peripheral blood mononuclear cells demonstrated pSTAT3 (Tyr(705)) inhibition following exposure. Two patients achieved partial responses at 5 mg intermittently and 4 mg continuously; both had epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer (NSCLC) with prior EGFR tyrosine kinase inhibitor exposure. CONCLUSION: OPB-51602 demonstrates promising antitumor activity, particularly in NSCLC. Its long half-life and poorer tolerability of continuous dosing, compared with intermittent dosing, suggest that less frequent dosing should be explored. CLINICALTRIALSGOV IDENTIFIER: NCT01184807.


Subject(s)
Antineoplastic Agents/pharmacokinetics , Biomarkers, Tumor/antagonists & inhibitors , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , STAT3 Transcription Factor/antagonists & inhibitors , Administration, Oral , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/adverse effects , Antineoplastic Agents/blood , Asia , Biomarkers, Tumor/genetics , Biomarkers, Tumor/metabolism , Biotransformation , Carcinoma, Non-Small-Cell Lung/blood , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/genetics , Dose-Response Relationship, Drug , Drug Administration Schedule , ErbB Receptors/genetics , Female , Half-Life , Humans , Lung Neoplasms/blood , Lung Neoplasms/diagnosis , Lung Neoplasms/genetics , Male , Maximum Tolerated Dose , Metabolic Clearance Rate , Middle Aged , Molecular Targeted Therapy , Mutation , Phosphorylation , STAT3 Transcription Factor/metabolism , Signal Transduction/drug effects , Treatment Outcome
3.
J Bone Joint Surg Br ; 93(4): 510-6, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21464492

ABSTRACT

Several bisphosphonates are now available for the treatment of osteoporosis. Porous hydroxyapatite/collagen (HA/Col) composite is an osteoconductive bone substitute which is resorbed by osteoclasts. The effects of the bisphosphonate alendronate on the formation of bone in porous HA/Col and its resorption by osteoclasts were evaluated using a rabbit model. Porous HA/Col cylinders measuring 6 mm in diameter and 8 mm in length, with a pore size of 100 µm to 500 µm and 95% porosity, were inserted into a defect produced in the lateral femoral condyles of 72 rabbits. The rabbits were divided into four groups based on the protocol of alendronate administration: the control group did not receive any alendronate, the pre group had alendronate treatment for three weeks prior to the implantation of the HA/Col, the post group had alendronate treatment following implantation until euthanasia, and the pre+post group had continuous alendronate treatment from three weeks prior to surgery until euthanasia. All rabbits were injected intravenously with either saline or alendronate (7.5 µg/kg) once a week. Each group had 18 rabbits, six in each group being killed at three, six and 12 weeks post-operatively. Alendronate administration suppressed the resorption of the implants. Additionally, the mineral densities of newly formed bone in the alendronate-treated groups were lower than those in the control group at 12 weeks post-operatively. Interestingly, the number of osteoclasts attached to the implant correlated with the extent of bone formation at three weeks. In conclusion, the systemic administration of alendronate in our rabbit model at a dose-for-weight equivalent to the clinical dose used in the treatment of osteoporosis in Japan affected the mineral density and remodelling of bone tissue in implanted porous HA/Col composites.


Subject(s)
Alendronate/pharmacology , Biocompatible Materials/pharmacology , Bone Density Conservation Agents/pharmacology , Osteoclasts/drug effects , Osteogenesis/drug effects , Osteoporosis/drug therapy , Alendronate/administration & dosage , Animals , Biocompatible Materials/administration & dosage , Bone Density Conservation Agents/administration & dosage , Case-Control Studies , Collagen , Durapatite/administration & dosage , Durapatite/pharmacology , Male , Models, Animal , Rabbits , Random Allocation
4.
Br J Ophthalmol ; 93(12): 1595-9, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19570766

ABSTRACT

AIM: To evaluate the relationship between vision-related quality of life (VR-QOL) and visual function in patients undergoing vitrectomy, gas tamponade and cataract surgery for macular hole (MH). METHODS: The 25-item National Eye Institute Visual Function Questionnaire (VFQ-25) was self-administered by 32 patients with MH (age 66.2 (SD 5.4) years) preoperatively and at 3 months postoperatively. Clinical data were collected, including logarithm of minimum angle of resolution (logMAR) best corrected visual acuity (BCVA), severity of metamorphopsia and letter contrast sensitivity. The severity of metamorphopsia was evaluated by the M-Charts. MH index was measured using optical coherence tomography. The presence and severity of cataract were graded using the Lens Opacities Classification System III reference standards. Multiple regression analysis was performed to investigate the relationship between various explanatory variables and VFQ-25 questionnaire scores. Explanatory variables tested were the severity of metamorphopsia, visual acuity, letter contrast sensitivity, MH index and grade of cataract. RESULTS: Vitrectomy for MH significantly improved VFQ-25 composite score as well as subscale scores, including general vision, near activities, distance activities, social functioning, mental health and dependency (p<0.05, Wilcoxon signed-rank test). Multiple regression analysis revealed that, both preoperatively and postoperatively, the severity of metamorphopsia had a significant correlation with VFQ-25 composite score (p<0.05), whereas other explanatory variables did not. In addition, changes in the severity of metamorphopsia was the single variable that was significantly related to changes in VFQ-25 composite score (p<0.01). CONCLUSION: Vitrectomy for MH significantly improved VR-QOL. The severity of metamorphopsia was significantly associated with both preoperative and postoperative VR-QOL.


Subject(s)
Cataract Extraction/rehabilitation , Quality of Life , Retinal Perforations/surgery , Vitrectomy/rehabilitation , Aged , Cataract/complications , Contrast Sensitivity , Female , Health Status Indicators , Humans , Male , Middle Aged , Prospective Studies , Retinal Perforations/complications , Retinal Perforations/rehabilitation , Treatment Outcome , Vision Disorders/etiology , Vision Disorders/rehabilitation , Visual Acuity
5.
Health promot. int ; 22(4): 292-298, Dec. 2007. tab
Article in English | CidSaúde - Healthy cities | ID: cid-59685

ABSTRACT

We developed the Emergence Model and introduced the concept of social and human capital into designing and evaluating the Healthy Cities/Municipalities project to ensure health promotion infrastructure. This model hypothesizes that through the interaction and utilization of the other forms of capital, namely financial, physical and natural, the emergence of collective action takes place in the community or municipal setting. Subsequently, collective action may influence health and quality of life determinants. Once health and quality of life improvements are achieved, the enhancement of the social, human and other capital may be brought about through positive feedback, and successive collective action is thereby facilitated. According to the model, practitioners and policy makers of the Healthy Cities/Municipalities project should primarily strengthen social and human capital. The model is currently applied to designing the Healthy Municipalities project implemented in rural areas of Northeast Brazil, where infrastructure and a supportive environment to facilitate collective action for control over health and health determinant have been considerably frail due to geographical, historical, social and cultural reasons. Various interventions have been conducted in the scope of the project to enhance social and human capital on three levels, namely the state, municipality and community. Through the capacity development of health promoters, obliging volunteers and so on, the project attempts to create the social mechanism that enables people to build healthy public policies through inter- and trans-sectoral collaboration as well as to address and resolve day-to-day issues using their potentialities. (AU)


Subject(s)
Humans , Health Promotion/methods , Health Promotion/organization & administration , Models, Organizational , Healthy City , Urban Health Services/economics , Brazil
6.
Int J Pharm ; 298(1): 13-25, 2005 Jul 14.
Article in English | MEDLINE | ID: mdl-15927427

ABSTRACT

The entrapment of kojic acid and its newly synthesized ester (kojic oleate) has been evaluated. Kojic oleate was synthesized by DCC (N,N'-dicyclohexylcarbodiimide, DCC)/(4-(N,N-dimethylamino)pyridine, DMAP) esterification method and identified by FAB-MS and 1H NMR. The synthesized product was mainly 7-O-kojic oleate with more than 80% yield. It was entrapped in vesicular membrane prepared from 9.5:9.5:1.0 molar ratio of amphiphiles (Span 60, Tween 61 or DPPC), cholesterol and dicetyl phosphate. Kojic acid was encapsulated in the water compartment of these vesicles in order to confirm the vesicle formation. The morphology and particle size of the vesicles were characterized by an optical microscope and transmission electron microscope (TEM). The entrapment efficiencies of kojic acid and kojic oleate in the vesicles were investigated by dialysis and column chromatography, respectively. The contents of the entrapped kojic acid and kojic oleate were assayed by HPLC. The entrapment efficiency of kojic acid was 0.01-0.04 mol, whereas kojic oleate gave higher entrapment efficiency of 0.25-0.35 mol/mol of the total compositions of amphiphile/cholesterol/dicetyl phosphate. Structural modification of kojic acid improved its entrapment in the vesicles. Tween 61 vesicles could entrap kojic oleate more than did Span 60 vesicles. The pi-A isotherms revealed the lower area per molecule of Span 60, which formed a more rigid pack of its molecule on air/water interface than that of Tween 61. This implied the high rigidity of vesicular membrane prepared with Span 60 led to the lower amount of kojic oleate entrapped in the vesicles. From the release study of kojic acid through the dialysis membrane, it indicated that the intercalation of kojic oleate in the vesicular membranes did not significantly affect the release of kojic acid from the vesicles.


Subject(s)
Lipid Bilayers/chemistry , Pyrones/chemistry , Androstanes/chemistry , Oleic Acid/chemistry , Surface Tension
7.
Nihon Koshu Eisei Zasshi ; 48(7): 513-20, 2001 Jul.
Article in Japanese | MEDLINE | ID: mdl-11524826

ABSTRACT

Primary Health Care is recognized as a core health strategy in developing countries, proclaimed by the Declaration at Alma-Ata, while for industrialized countries, Health Promotion was stated in the Ottawa Charter. The concept of Primary Health Care, having been influenced by the Social Development movement for basic human needs in the 70s, is almost entirely consistent with Health Promotion, which is in accord with the principles of Human Development pronounced in the late 80s through the 90s. Thus, Health Promotion could be developed as a health strategy also in developing countries while Primary Health Care could similarly be adopted as a health strategy in the industrialized world.


Subject(s)
Health Promotion , Primary Health Care , Developing Countries
8.
Radiat Med ; 19(2): 107-10, 2001.
Article in English | MEDLINE | ID: mdl-11383641

ABSTRACT

We report a case of asymptomatic bronchial atresia of the anterobasal and laterobasal segments of the right lower lobe. Because of the absence of typical bronchial mucocele on chest radiograph, it was difficult to base the diagnosis on chest radiography alone. Helical CT images demonstrated the characteristic appearance of bronchial atresia, and three-dimensional (3D) CT bronchography using the volume rendering technique helped us to comprehend the spatial relationship between the dilated bronchus distal to the atresia and the more proximal bronchus.


Subject(s)
Bronchi/abnormalities , Bronchography/methods , Imaging, Three-Dimensional , Tomography, X-Ray Computed/methods , Adult , Humans , Image Processing, Computer-Assisted , Male
9.
J Bacteriol ; 183(8): 2614-23, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11274122

ABSTRACT

Replication factor C (RFC) and proliferating cell nuclear antigen (PCNA) are accessory proteins essential for processive DNA synthesis in the domain Eucarya. The function of RFC is to load PCNA, a processivity factor of eukaryotic DNA polymerases delta and epsilon, onto primed DNA templates. RFC-like genes, arranged in tandem in the Pyrococcus furiosus genome, were cloned and expressed individually in Escherichia coli cells to determine their roles in DNA synthesis. The P. furiosus RFC (PfuRFC) consists of a small subunit (RFCS) and a large subunit (RFCL). Highly purified RFCS possesses an ATPase activity, which was stimulated up to twofold in the presence of both single-stranded DNA (ssDNA) and P. furiosus PCNA (PfuPCNA). The ATPase activity of PfuRFC itself was as strong as that of RFCS. However, in the presence of PfuPCNA and ssDNA, PfuRFC exhibited a 10-fold increase in ATPase activity under the same conditions. RFCL formed very large complexes by itself and had an extremely weak ATPase activity, which was not stimulated by PfuPCNA and DNA. The PfuRFC stimulated PfuPCNA-dependent DNA synthesis by both polymerase I and polymerase II from P. furiosus. We propose that PfuRFC is required for efficient loading of PfuPCNA and that the role of RFC in processive DNA synthesis is conserved in Archaea and Eucarya.


Subject(s)
Bacterial Proteins/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/metabolism , Homeodomain Proteins , Proteins/genetics , Proto-Oncogene Proteins c-bcl-2 , Repressor Proteins , Saccharomyces cerevisiae Proteins , Adenosine Triphosphatases/metabolism , Archaeal Proteins/genetics , Archaeal Proteins/metabolism , Bacterial Proteins/metabolism , Cloning, Molecular , DNA Polymerase I/metabolism , DNA Polymerase II/metabolism , DNA Replication , DNA, Archaeal/metabolism , Genes, Archaeal , Minor Histocompatibility Antigens , Molecular Sequence Data , Phylogeny , Proliferating Cell Nuclear Antigen/metabolism , Proteins/metabolism , Pyrococcus furiosus/genetics , Pyrococcus furiosus/metabolism , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Replication Protein C , Temperature
10.
Oncogene ; 19(41): 4721-8, 2000 Sep 28.
Article in English | MEDLINE | ID: mdl-11032022

ABSTRACT

The xeroderma pigmentosum variant (XP-V) is one of the most common forms of this cancer-prone syndrome. XP groups A through G are characterized by defective nucleotide excision repair, whereas the XP-V phenotype is proficient in this pathway. The XPV gene encodes DNA polymerase eta, which catalyzes an accurate translesion synthesis, indicating that the XPV gene contributes tumor suppression in normal individuals. Here we describe the genomic structure and chromosomal localization of the XPV gene, which includes 11 exons covering the entire coding sequence, lacks a TATA sequence in the upstream region of the transcription-initiation, and is located at the chromosome band 6p21.1-6p12. Analyses of patient-derived XP-V cell lines strongly suggested that three of four cell lines carried homozygous mutations in the XPV gene. The fourth cell line, XP1RO, carried heterozygous point mutations in the XPV gene, one of which was located at the splice acceptor site of exon 2, resulting in the omission of exon 2 from the mature mRNA. These findings provide a basis for diagnosis and therapy of XP-V patients.


Subject(s)
Chromosomes, Human, Pair 6/genetics , DNA-Directed DNA Polymerase/genetics , Genes , Xeroderma Pigmentosum/genetics , Alleles , Animals , Base Sequence , Cell Line , Chromosome Mapping , Chromosomes, Artificial, Human , DNA Mutational Analysis , Exons/genetics , HeLa Cells , Humans , Hybrid Cells , In Situ Hybridization, Fluorescence , Introns/genetics , Mice , Molecular Sequence Data , Transcription, Genetic , Xeroderma Pigmentosum/pathology
11.
Am J Physiol Heart Circ Physiol ; 279(3): H908-15, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10993749

ABSTRACT

The effect of molecular dimension of hemoglobin (Hb)-based O(2) carriers on the diameter of resistance arteries (A(0), 158 +/- 21 microm) and arterial blood pressure were studied in the conscious hamster dorsal skinfold model. Cross-linked Hb (XLHb), polyethylene glycol (PEG)-conjugated Hb, hydroxyethylstarch-conjugated XLHb, polymerized XLHb, and PEG-modified Hb vesicles (PEG-HbV) were synthesized. Their molecular diameters were 7, 22, 47, 68, and 224 nm, respectively. The bolus infusion of 7 ml/kg of XLHb (5 g/dl) caused an immediate hypertension (+34 +/- 13 mmHg at 3 h) with a simultaneous decrease in A(0) diameter (79 +/- 8% of basal value) and a blood flow decrease throughout the microvascular network. The diameter of smaller arterioles did not change significantly. Infusion of larger O(2) carriers resulted in lesser vasoconstriction and hypertension, with PEG-HbV showing the smallest changes. Constriction of resistance arteries was found to be correlated with the level of hypertension, and the responses were proportional to the molecular dimensions of the O(2) carriers. The underlying mechanism is not evident from these experiments; however, it is likely that the effects are related to the diffusion properties of the different Hb molecules.


Subject(s)
Arteries/drug effects , Hemoglobins/metabolism , Hypertension/chemically induced , Vascular Resistance/drug effects , Animals , Blood Substitutes/administration & dosage , Blood Substitutes/chemistry , Cricetinae , Drug Carriers , Hemoglobins/administration & dosage , Humans , Hypertension/metabolism , Liposomes , Male , Mesocricetus , Microcirculation/drug effects , Oxygen/metabolism , Polyethylene Glycols/chemistry , Polymers/chemistry , Vasoconstriction/drug effects
12.
Bioconjug Chem ; 11(1): 56-64, 2000.
Article in English | MEDLINE | ID: mdl-10639086

ABSTRACT

A series of hemoglobin (Hb)-based O(2) carriers, acellular and cellular types, were synthesized and their physicochemical characteristics were compared. The acellular type includes intramolecularly cross-linked Hb (XLHb), polyoxyethylene (POE)-conjugated pyridoxalated Hb (POE-PLP-Hb), hydroxyethylstarch-conjugated Hb (HES-XLHb), and glutaraldehyde-polymerized XLHb (Poly-XLHb). The cellular type is Hb-vesicles (HbV) of which the surface is modified with POE (POE-HbV). Their particle diameters are 7 +/- 2, 22 +/- 2, 47 +/- 17, 68 +/- 24, and 224 +/- 76 nm, respectively, thus all the materials penetrate across membrane filters with 0.4 microm pore size, though only the POE-HbV cannot penetrate across the filter with 0.2 microm pore size. These characteristics of permeability are important to consider an optimal particle size in microcirculation in vivo. POE-PLP-Hb ([Hb] = 5 g/dL) showed viscosity of 6.1 cP at 332 s(-1) and colloid osmotic pressure (COP) of 70.2 Torr, which are beyond the physiological conditions (human blood, viscosity = 3-4 cP, COP = ca. 25 Torr). XLHb and Poly-XLHb showed viscosities of 1.0 and 1.5 cp, respectively, which are significantly lower than that of blood. COP of POE-HbV is regulated to 20 Torr in 5% human serum albumin (HSA). HES-XLHb and POE-HbV/HSA showed comparable viscosity with human blood. Microscopic observation of human red blood cells (RBC) after mixing blood with POE-PLP-Hb or HES-XLHb disclosed aggregates of RBC, a kind of sludge, indicating a strong interaction with RBC, which is anticipated to modify peripheral blood flow in vivo. On the other hand, XLHb and POE-HbV showed no rouleaux or aggregates of RBC. The acellular Hbs (P(50) = 14-32 Torr) have their specific O(2) affinities determined by their structures, while that of the cellular POE-HbV is regulated by coencapsulating an appropriate amount of an allosteric effector (e.g., P(50) = 18, 32 Torr). These differences in physicochemical characteristics between the acellular and cellular types indicate the advantages of the cellular type from the physiological points of view.


Subject(s)
Blood Substitutes/chemistry , Blood Substitutes/chemical synthesis , Hemoglobins/chemistry , Hemoglobins/chemical synthesis , Oxygen/chemistry , Blood Substitutes/metabolism , Blood Substitutes/pharmacology , Colloids/chemistry , Erythrocyte Aggregation/drug effects , Erythrocytes/drug effects , Glutaral/blood , Glutaral/chemistry , Hemoglobins/metabolism , Hemoglobins/pharmacology , Humans , Hydroxyethyl Starch Derivatives/chemical synthesis , Hydroxyethyl Starch Derivatives/chemistry , Hydroxyethyl Starch Derivatives/metabolism , Molecular Weight , Osmotic Pressure , Oxygen/administration & dosage , Oxygen/blood , Particle Size , Polyethylene Glycols/chemical synthesis , Polyethylene Glycols/chemistry , Polyethylene Glycols/metabolism , Viscosity
14.
Nihon Igaku Hoshasen Gakkai Zasshi ; 59(13): 760-4, 1999 Nov.
Article in Japanese | MEDLINE | ID: mdl-10614107

ABSTRACT

Table-moving contrast-enhanced MR angiography (MRA) was performed in 14 cases of abdominal aortic aneurysm to evaluate its clinical usefulness. In all cases, aneurysms were clearly demonstrated and image quality was clinically acceptable. Findings of reconstructed MRA were highly consistent with those of DSA, and thrombosed areas were confirmed on source images. Main aortic branches including renal arteries, common iliac arteries, and internal and external iliac arteries were readily identified on reconstructed MRA and/or source images. Additional findings such as thoracic aortic aneurysm (n = 1), common iliac aneurysm (n = 6), external iliac aneurysm (n = 1), internal iliac aneurysm (n = 1), femoral arterial obstruction (n = 2), and femoral arterial stenosis (n = 4) were also detected. Although table-moving MRA may have disadvantages like reduced blood signal and limited spatial resolution compared with the conventional contrast-enhanced technique, the images that were obtained provided sufficient contrast and resolution for preoperative evaluation. Because abdominal aortic aneurysm is accompanied by various arterial abnormalities in many of the large arteries, table-moving MRA was considered a suitable technique for comprehensive assessment.


Subject(s)
Aortic Aneurysm, Abdominal/diagnosis , Image Enhancement , Magnetic Resonance Angiography/methods , Aged , Contrast Media/administration & dosage , Female , Humans , Magnetic Resonance Angiography/instrumentation , Male , Middle Aged
15.
Drug Des Discov ; 16(2): 171-5, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10533813

ABSTRACT

A new series of 5-substituted and 5-nonsubstituted pyrazolopyrrolopyrimidine derivatives were synthesized, and their vasorelaxing and hypotensive activities were evaluated. The syntheses were efficiently accomplished through the use of three key intermediates (7, 16, and 24), as shown in Schemes I-III. The desired pharmacological activities were confirmed on the basis of vasorelaxing activity in rat aorta (in vitro) and hypotensive activity in rats (in vivo). Specifically, compound 25 exhibited the strongest activity and appears to be a promising clinical lead for the development of a new antihypertensive agent.


Subject(s)
Muscle Relaxation/drug effects , Muscle, Smooth, Vascular/drug effects , Pteridines/pharmacology , Vasodilator Agents/chemical synthesis , Vasodilator Agents/pharmacology , Animals , Antihypertensive Agents/pharmacology , Aorta/drug effects , In Vitro Techniques , Pteridines/chemical synthesis , Rats
16.
Life Sci ; 65(13): 1423-31, 1999.
Article in English | MEDLINE | ID: mdl-10503961

ABSTRACT

The Long Evans Cinnamon (LEC) rat, which accumulates excess Cu in the liver as in patients with Wilson's disease, is a mutant strain displaying spontaneous hepatitis. It was reported that Fe, like Cu, increases in the liver and that the severity of hepatitis is modified by Fe in the diet. In this experiment, oxidative stress increased by Fe was investigated before the onset of hepatitis. To examine the effect of Fe on the progress into hepatitis, LEC female rats were fed an Fe-regular (Fe 214 microg/g; Fe(+) group) or an Fe-restricted (Fe 14 microg/g; Fe(-) group) diet from 53 days of age for 35 days. Fischer rats were also fed as control animals. Adenine nucleotide decomposition was determined as an index of oxidative stress based on xanthine oxidase activity. The size of the hepatic pool of adenine nucleotides (ATP+ADP+AMP) was significantly smaller in LEC rats than Fischer rats. The energy charge (ATP+0.5ADP)/(ATP+ADP+AMP) was smaller in Fe(+) groups than in Fe(-) groups. In the LEC rat liver, the Fe concentration in the Fe(+) group was 160% of that in Fe(-) group and the correlation coefficient between the hepatic Fe concentration and the energy charge was significant. In this strain, an increase of xanthine oxidase activity resulted in an increase of xanthine, an oxidized metabolite of hypoxanthine in the liver. The results suggest the involvement of the Fe in the progression into hepatitis in the LEC rat, even if the dietary Fe concentration is similar to that of commercial diet.


Subject(s)
Adenine Nucleotides/metabolism , Disease Models, Animal , Hepatolenticular Degeneration/metabolism , Iron/metabolism , Liver/metabolism , Xanthine Oxidase/metabolism , Animals , Copper/metabolism , Female , Rats , Rats, Inbred F344 , Rats, Long-Evans , Reactive Oxygen Species
17.
Nature ; 399(6737): 700-4, 1999 Jun 17.
Article in English | MEDLINE | ID: mdl-10385124

ABSTRACT

Xeroderma pigmentosum variant (XP-V) is an inherited disorder which is associated with increased incidence of sunlight-induced skin cancers. Unlike other xeroderma pigmentosum cells (belonging to groups XP-A to XP-G), XP-V cells carry out normal nucleotide-excision repair processes but are defective in their replication of ultraviolet-damaged DNA. It has been suspected for some time that the XPV gene encodes a protein that is involved in trans-lesion DNA synthesis, but the gene product has never been isolated. Using an improved cell-free assay for trans-lesion DNA synthesis, we have recently isolated a DNA polymerase from HeLa cells that continues replication on damaged DNA by bypassing ultraviolet-induced thymine dimers in XP-V cell extracts. Here we show that this polymerase is a human homologue of the yeast Rad30 protein, recently identified as DNA polymerase eta. This polymerase and yeast Rad30 are members of a family of damage-bypass replication proteins which comprises the Escherichia coli proteins UmuC and DinB and the yeast Rev1 protein. We found that all XP-V cells examined carry mutations in their DNA polymerase eta gene. Recombinant human DNA polymerase eta corrects the inability of XP-V cell extracts to carry out DNA replication by bypassing thymine dimers on damaged DNA. Together, these results indicate that DNA polymerase eta could be the XPV gene product.


Subject(s)
DNA-Directed DNA Polymerase/genetics , Xeroderma Pigmentosum/genetics , Alleles , Amino Acid Sequence , Animals , Cell Line , Cell-Free System , Cloning, Molecular , DNA Repair , HeLa Cells , Humans , Molecular Sequence Data , Mutation , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Saccharomyces cerevisiae/enzymology , Sequence Homology, Amino Acid , Xeroderma Pigmentosum/enzymology , DNA Polymerase iota
18.
Zentralbl Veterinarmed B ; 46(3): 207-15, 1999 Apr.
Article in English | MEDLINE | ID: mdl-10337243

ABSTRACT

In cattle, we encountered insulin-dependent diabetes mellitus (IDDM) associated with bovine viral diarrhoea virus (BVDV) infection. To estimate the correlation between IDDM and BVDV infection, the distribution of BVDV in the pancreas and islet-cell antibody (ICA) were investigated. The distribution of BVDV in the pancreas was examined by in situ hybridization using two oligonucleotide probes that recognized the gp25- and p14-coding regions of the BVDV gene. ICA was examined by indirect fluorescence antibody assay using the sera from affected cattle and pancreata from normal cattle. In the pancreata of all BVDV-infected cattle, including IDDM-complicated cattle, oligonucleotide probe hybridized portions were recognized. In short, BVDV genes were detected not only in IDDM-complicated cattle but also in uncomplicated cattle. Moreover, there was no hybridized portion in the islet cells. In BVDV-infected and IDDM-complicated cattle, ICA was frequently detected. On the other hand, ICA was not detected in BVDV-infected and IDDM uncomplicated cattle. These results suggest that IDDM associated with BVDV infection is not a direct effect of BVDV on islet cells. Therefore, as BVDV did not induce IDDM in any cases, it appears that BVDV does not induce IDDM directly, but rather may be an autoimmune disease induced by autoantibodies against islet cells.


Subject(s)
Bovine Virus Diarrhea-Mucosal Disease/complications , Cattle Diseases/virology , Diabetes Mellitus, Type 1/veterinary , Diarrhea Viruses, Bovine Viral/isolation & purification , Pancreas/virology , Animals , Autoantibodies/analysis , Bovine Virus Diarrhea-Mucosal Disease/pathology , Cattle , Cattle Diseases/pathology , Diabetes Mellitus, Type 1/pathology , Diabetes Mellitus, Type 1/virology , Female , In Situ Hybridization , Islets of Langerhans/immunology , Pancreas/pathology
19.
Appl Radiat Isot ; 50(3): 531-3, 1999 Mar.
Article in English | MEDLINE | ID: mdl-10070713

ABSTRACT

(beta-Hydroxyethyl)tri([11C]methyl)ammonium ([11C]choline) is a tracer very effective in imaging various human tumors using positron emission tomography (PET). We have constructed a computer-controlled [11C]choline synthetic apparatus which carries out the whole process of synthesis and product purification automatically. The setup is simple and the process quick. In 20 min, 11 GBq of [11C]choline (chloride) is obtainable from 26 GBq of [11C]CO2. The final product is a sterile and pyrogen-free [11C]choline "injection".


Subject(s)
Carbon Radioisotopes , Choline/chemical synthesis , Neoplasms/diagnostic imaging , Radiopharmaceuticals/chemical synthesis , Tomography, Emission-Computed/methods , Humans , Technology, Radiologic/instrumentation
20.
Science ; 283(5404): 975-7, 1999 Feb 12.
Article in English | MEDLINE | ID: mdl-9974388

ABSTRACT

Manned submersible studies have delineated a large and actively growing Kuroko-type volcanogenic massive sulfide deposit 400 kilometers south of Tokyo in Myojin Knoll submarine caldera. The sulfide body is located on the caldera floor at a depth of 1210 to 1360 meters, has an area of 400 by 400 by 30 meters, and is notably rich in gold and silver. The discovery of a large Kuroko-type polymetallic sulfide deposit in this arc-front caldera raises the possibility that the numerous unexplored submarine silicic calderas elsewhere might have similar deposits.

SELECTION OF CITATIONS
SEARCH DETAIL
...